InfraCap MLP ETF (NYSE: AMZA) Declares Quarterly Dividend

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
72
InfraCap MLP ETF (NYSE: AMZA) Declares Quarterly Dividend

NEW YORK, NY--(Marketwired - Apr 3, 2017) -  The InfraCap MLP ETF ( NYSE : AMZA ) has declared a quarterly dividend of $0.52 ($2.08 per share on an annualized basis). The dividend will be paid April 13, 2017 to shareholders of record as of the close of business April 06, 2017.

AMZA Cash Distribution:

  • Ex-Date: Tuesday, April 04 th
  • Record Date: Thursday, April 06 th
  • Payable Date: Thursday, April 13 th

Infrastructure Capital Advisors expects to declare future dividends on a quarterly basis. Dividends are planned, but not guaranteed, for the months of January, April, July, and October of each year. The next dividend is scheduled to occur in July 2017.

ABOUT INFRASTRUCTURE CAPITAL ADVISORS, LLC

Infrastructure Capital Advisors, LLC is an SEC-registered investment advisor that manages an actively managed ETF and a series of private investment partnerships. The firm was formed in 2012 and is based in New York City. The company seeks total-return opportunities in key infrastructure sectors, including energy, real estate, transportation, industrials and utilities. It often identifies opportunities in entities that are not taxed at the entity level, such as master limited partnerships ("MLPs") and real estate investment trusts ("REITs"). Current income is a primary objective in most, but not all, of the company's investing activities. The focus is generally on asset-intensive companies that generate and distribute substantial streams of free cash flow. For more information, please visit www.infracapmlp.com .

DISCLOSURE

Fund Risks

Exchange Traded Funds: The value of an ETF may be more volatile than the underlying portfolio of securities the ETF is designed to track. The costs of owning the ETF may exceed the cost of investing directly in the underlying securities.

MLP Interest Rates: As yield-based investments, MLPs carry interest rate risk and may underperform in rising interest rate environments. Additionally, when investors have heightened fears about the economy, the risk spread between MLPs and competing investment options can widen, which may have an adverse effect on the stock price of MLPs. Rising interest rates may increase the potential cost of MLPs financing projects or cost of operations, and may affect the demand for MLP investments, either of which may result in lower performance by or distributions from the Fund's MLP investments.

Industry/Sector Concentration: A fund that focuses its investments in a particular industry or sector will be more sensitive to conditions that affect that industry or sector than a non-concentrated fund.

Short Sales: The fund may engage in short sales, and may experience a loss if the price of a borrowed security increases before the date on which the fund replaces the security.

Leverage: When a fund leverages its portfolio, the value of its shares may be more volatile and all other risks may be compounded.

Derivatives: Investments in derivatives such as futures, options, forwards, and swaps may increase volatility or cause a loss greater than the principal investment.

MLPs: Investments in Master Limited Partnerships may be adversely impacted by tax law changes, regulation, or factors affecting underlying assets.

No Guarantee: There is no guarantee that the portfolio will meet its objective.

You should consider the fund's investment objectives, risks, and charges and expenses carefully before investing. Contact ETF Distributors LLC at 1-888-383-4184 or visit www.infracapmlp.com to obtain a prospectus which contains this and other information about the fund. The prospectus should be read carefully before investing.

Virtus ETF Advisers, LLC serves as the investment advisor and Infrastructure Capital Advisors, LLC serves as the sub-advisor to the Fund.

The Fund is distributed by ETF Distributors LLC, an affiliate of Virtus ETF Advisers, LLC.

Contacts: Fund Information: ETF Distributors LLC Phone: 212-593-4383 or 1-888-383-4184 (toll free) Email: info@etfis.com Media: Haley Rosa GREGORY FCA Phone: 610-228-2805 Email: haley@gregoryfca.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Trilith Holiday Tour Blends Film Access and Giving

Updated Category News Views 53

Snow machines, trolley rides, and a mental-health subsidy are sharing the same stage in Fayetteville this holiday season. That is an unusual mix, but it fits Trilith Foundation’s stated mission better than another generic lights-and-cocoa event ever could. From Nov. 21 through Dec. 31, the Foundation is turning its guided Trilith Studios tour into a seasonal experience...

Continue Reading
LASIK Cost Math Deserves a Careful Second Look Today

Updated Category News Views 66

Thirty years of lens purchases can become a nasty tab Contact-lens spending has a funny way of staying invisible until somebody stacks the receipts into one ugly pile. A new cost-of-vision analysis from the surgeon advisory board of BestLASIKSurgeons.com says the average American contact-lens wearer may spend between $22,500 and $30,000 on corrective eyewear across 30...

Continue Reading
Stand Takes Colorado Bet on Wildfire-Smart Coverage

Updated Category News Views 90

Colorado’s insurance mess has finally attracted a company willing to price the driveway, the vents, and the tree line instead of shrugging at an entire ZIP code. Stand has launched homeowners coverage across the state, including mountain communities where wildfire exposure has made insurance both costly and scarce. This is not a small problem dressed up with a shiny...

Continue Reading
Medical School Rejections Carry a Steep Price Tag Too

Updated Category News Views 81

A rejection letter can turn into a remarkably expensive piece of paper. BeMo Academic Consulting's new Medical School Admissions Trends Report argues that the damage from missing medical-school admission goes far beyond bruised confidence: applicants can spend thousands chasing another cycle, lose time entering practice, and, if they never get in, forgo what the report...

Continue Reading
AI Echo Study Sharpens a Difficult HFpEF Diagnosis

Updated Category News Views 71

A single echo clip may be doing more useful work than plenty of flashy healthcare AI demos. The November 2026 Journal of Cardiac Failure focus issue puts a hard number on that possibility: pairing an AI read of a routine echocardiogram clip with the H?FPEF clinical score identified 78% of patients with hemodynamically confirmed HFpEF, versus 48% with the score alone. That...

Continue Reading
Makers Nutrition Credit Puts a Clock on New Brands

Updated Category News Views 124

A few cents per bottle can look downright beautiful when a new supplement brand is staring at its first production bill. Makers Nutrition announced on November 17 a Black Friday manufacturing-credit offer aimed at entrepreneurs and established sellers launching a new formulation, with qualifying new orders eligible for as much as $0.45 per unit through November 29, 2026....

Continue Reading
AMPERA Joins Berto to Power Future Energy Innovations

Updated Category News Views 58

The Power Play You Didn't See Coming AMPERA and Berto just made a move that could stir up some serious waves in the energy sector. They've inked a business combination deal set to push advanced energy technology to the forefront. With AMPERA's valuation clocking in at roughly $900 million, this partnership aims to bring cutting-edge power solutions from concept to market....

Continue Reading
My Home Delivery's Bold Move in Big & Bulky Sector

Updated Category News Views 67

Redefining Big & Bulky Deliveries with AI Let me tell you, the logistics world isn't for the timid, and My Home Delivery (MHD) is swinging for the fences with their latest tech platform. These folks are rolling out an AI-driven system that promises to turn the bulky goods market on its head. Imagine moving your brand new fridge or that king-size bed across town without...

Continue Reading
Paratus on the Move: Seagems JV Under the Microscope

Updated Category News Views 20

What's Cooking with Paratus Energy? Paratus Energy Services Ltd. (ticker: PLSV) just threw us a curveball, announcing a strategic review of its participation in the Seagems joint venture. Now, before you get too jazzed about ticker talk—hold your horses. No one's making any promises about transactions just yet. The decision's still hanging in the balance, even as they...

Continue Reading
Alpha's Training Bet Reaches Into Aesthetic Care Networks

Updated Category News Views 146

Training is becoming part of the operating machine A certificate course is rarely the headline-grabber in healthcare services, yet this one deserves a closer look. Alpha Aesthetics Partners has launched Practice Aesthetics, a unified clinical education platform tied directly to its expanding network of medical aesthetics practices. This is not a public-market ticker...

Continue Reading

Top 5 Most Recently Viewed Articles

Mary Kay's Continued Commitment to Sustainability Recognition

Updated Category News Views 342

Mary Kay's Commitment to Sustainability Recognized Again Mary Kay Inc., a global leader in skincare innovation and sustainability, has been recognized once more with the esteemed 2024 Texan by Nature 20 (TxN 20) award. This prestigious accolade, awarded by the non-profit organization Texan by Nature, highlights businesses in Texas that exemplify strong commitments to...

Continue Reading
A Bitcoin Whale Stirs After Years: What it Means for 2025

Updated Category News Views 549

Dormant Bitcoin Address Reawakens Recently, data from Blockchain tracker Whale Alert revealed the activity of a long-dormant Bitcoin address. This particular account has remained inactive for over 11 years and contains a significant holding of 357 BTC, estimated to be worth around $34,070,177 today. Such dormant addresses tend to generate intrigue within the...

Continue Reading
Artelo Biosciences Progresses with Innovative Pain Treatment Clinical Trials

Updated Category News Views 114

Artelo Biosciences Takes Significant Steps Forward Artelo Biosciences, Inc. (Nasdaq: ARTL), a pioneering clinical-stage pharmaceutical company, has achieved an important milestone with the successful completion of the first cohort in its Phase 1 study of ART26.12, a selective Fatty Acid Binding Protein 5 (FABP5) inhibitor. This marks a distinctive moment in the landscape...

Continue Reading
Empowering Youth: Leadership Growth Through Camp Initiatives

Updated Category News Views 303

Empowering Youth through Leadership Development at Camps Youth with disabilities and illnesses often face unique challenges that can impact their personal development and leadership skills. In a bid to address these challenges, a groundbreaking collaborative initiative has emerged, aimed at promoting character and leadership development in these young individuals. By...

Continue Reading
Understanding Man Group PLC's Recent Disclosure and Position

Updated Category News Views 251

Overview of Disclosures by Man Group PLC Man Group PLC recently submitted a significant disclosure in line with the Takeover Code, showcasing critical insights into their positions and dealings within the market. This comprehensive disclosure serves as an essential tool for analysts and investors alike to understand the company's strategic maneuvers, particularly with...

Continue Reading